Look for:

Our offer for

REVVITY INC.


ISIN:
US7140461093
WKN:
714046109
2024/05/02 08:10:10
Price
95.20 EUR
Difference -2.44% (-2.38)

General attributes

ISINUS7140461093
SymbolRVTY
ExchangeDuesseldorf
CurrencyEUR
SectorTechnology
Security typeStock
Market cap (m)11,637 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)-
Ask (Ask size)-
Open95.20 EUR
High95.20 EUR
Low95.20 EUR
Close (prev. day)97.58 EUR
VWAP-
Volume (pcs)0
Trading volume0.00
Number of trades3
Last size0

Futures and Options

Related Futures-
Related Options-

PDF Downloads

Company report: REVVITY INC.PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2024/05/02 08:10:10
Price
95.20 EUR
Difference -2.44% (-2.38)

General attributes

ISINUS7140461093
SymbolRVTY
ExchangeDuesseldorf
CurrencyEUR
SectorTechnology
Security typeStock
Market cap (m)11,637 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)-
Ask (Ask size)-
Open95.20 EUR
High95.20 EUR
Low95.20 EUR
Close (prev. day)97.58 EUR
VWAP-
Volume (pcs)0
Trading volume0.00
Number of trades3
Last size0

Performance and Risk

6m1Y3Y
Perf (%)+20.51%-18.98%-11.93%
Perf (abs.)+16.20-22.30-12.90
Beta1.290.741.01
Volatility28.9631.4230.82
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)95.51 EUR (0)
Ø price 30 days | Ø volume 30 days (pcs.)95.76 EUR (1)
Ø price 100 days | Ø volume 100 days (pcs.)96.14 EUR (0)
Ø price 250 days | Ø volume 250 days (pcs.)99.05 EUR (1)
YTD High | date101.75 EUR (2024/01/31)
YTD Low | date92.34 EUR (2024/04/19)
52 Weeks High | date119.25 EUR (2023/07/27)
52 Weeks Low | date76.10 EUR (2023/10/30)

All listings for REVVITY INC.

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Tradegate2024/05/0222:2694.24 EUR0.003
Stuttgart2024/05/0215:3295.98 EUR0.005
NYSE2024/05/0222:00101.08 USD68.3717,006
Munich2024/05/0208:0496.18 EUR0.001
London Stock Exchange2024/03/2515:25103.39 USD0.001
Frankfurt2024/05/0216:0193.92 EUR0.003
Duesseldorf2024/05/0208:1095.20 EUR0.003
Berlin2024/05/0208:0895.20 EUR0.002

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=799&ID_TYPE_IMAGE_LOGO=2

Contact Details

REVVITY INC.
- -
940 Winter Street - 02451 Waltham
Telefon: +1-781-663-6900
Fax: +
E-mail: -

PDF Downloads

Company report: REVVITY INC.PDF Download

Company Profile

Revvity, Inc. provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. It focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, and informatics. With a global network and localized agility, the company serves a diverse range of organizations from pharmaceutical and biotech to clinical labs, academia, and governments. It is headquartered in Waltham, MA.

Members of Management Board

Alexis MichasChairman of Board of Directors
Franklin WitneyMember of Board of Directors
Michelle McMurry-HeathMember of Board of Directors
Peter BarrettMember of Board of Directors
Sophie VandebroekMember of Board of Directors
Sylvie GrégoireMember of Board of Directors
Michael KlobucharMember of Board of Directors
Michel VounatsosMember of Board of Directors
Pascale WitzMember of Board of Directors
Samuel ChapinMember of Board of Directors
Prahlad SinghChairman of Managing Board
Anita GonzalesMember of Executive Committee
Maxwell KrakowiakMember of Executive Committee






Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer